A novel multidrug resistance phenotype of bladder tumor cells grown on Matrigel or SIS gel

被引:11
作者
Hurst, RE
Kamat, CD
Kyker, KD
Green, DE
Ihnat, MA
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73190 USA
关键词
drug resistance; bladder carcinoma; Matrigel; SIS gel; extracellular matrix;
D O I
10.1016/j.canlet.2004.07.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have previously shown that growth of bladder carcinoma cell lines onto matrices such as Matrigel and small intestinal submucosal (SIS) gel cause distinct changes in cellular morphology and motility. In these studies, we found that bladder cells brown on Matrigel showed increased resistance to either doxorubicin or mitomycin-C whereas growth of cells in SIS gel caused either significant increases or little difference in drug resistance, depending on both the cells and the drug. Finally, it was found that this altered drug sensitivity is reversible with a finite half-life and is likely due to altered drug accumulation and/or cell cycle kinetics. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 33 条
[11]   INCREASED DRUG-RESISTANCE OF CULTURED HUMAN CANCER CELL-LINES IN 3-DIMENSIONAL CELLULAR GROWTH ASSAY USING COLLAGEN GEL MATRIX [J].
FURUKAWA, T ;
KUBOTA, T ;
WATANABE, M ;
KASE, S ;
SAIKAWA, Y ;
NISHIBORI, H ;
KUO, TH ;
KODAIRA, S ;
ISHIBIKI, K ;
KITAJIMA, M .
JOURNAL OF SURGICAL ONCOLOGY, 1992, 49 (02) :86-92
[12]   Inhibitors of ATP-binding cassette transporters suppress interleukin-12 p40 production and major histocompatibility complex II up-regulation in macrophages [J].
Haskó, G ;
Deitch, EA ;
Németh, ZH ;
Kuhel, DG ;
Szabó, C .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :103-110
[13]   Lipids as a target for drugs modulating multidrug resistance of cancer cells [J].
Hendrich, AB ;
Michalak, K .
CURRENT DRUG TARGETS, 2003, 4 (01) :23-30
[14]   Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer [J].
Herr, HW ;
Donat, SM ;
Bajorin, DF .
JOURNAL OF UROLOGY, 2001, 165 (03) :811-814
[15]  
Hurst RE, 2003, ANTICANCER RES, V23, P3119
[16]  
Ihnat MA, 1997, CLIN CANCER RES, V3, P1339
[17]   ISOLATION AND CHARACTERIZATION OF TYPE-IV PROCOLLAGEN, LAMININ, AND HEPARAN-SULFATE PROTEOGLYCAN FROM THE EHS SARCOMA [J].
KLEINMAN, HK ;
MCGARVEY, ML ;
LIOTTA, LA ;
ROBEY, PG ;
TRYGGVASON, K ;
MARTIN, GR .
BIOCHEMISTRY, 1982, 21 (24) :6188-6193
[18]   ACQUIRED MULTICELLULAR-MEDIATED RESISTANCE TO ALKYLATING-AGENTS IN CANCER [J].
KOBAYASHI, H ;
MAN, S ;
GRAHAM, CH ;
KAPITAIN, SJ ;
TEICHER, BA ;
KERBEL, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3294-3298
[19]   A model for 3-dimensional growth of bladder cancers to investigate cell-matrix interactions [J].
Kyker, KD ;
Culkin, DJ ;
Hurst, RE .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (04) :255-261
[20]   Chemotherapy in the post-MVAC era:: the case for adjuvant chemotherapy [J].
Lehmann, J ;
Retz, M ;
Stöckle, M .
WORLD JOURNAL OF UROLOGY, 2002, 20 (03) :144-150